Pharmacological Activation of HMN for OSA Aim 2
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT03858751
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Obstructive Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Placebo oral capsule — DRUGPlacebo capsule before bedtime
- LTM1201AZ — DRUGLTM1201AZ oral capsule before sleep
- LTM1201AT — DRUGLTM1201AT oral capsule before sleep
- LTM1201AG — DRUGLTM1201AG oral capsule before sleep
- LTM1201AD — DRUGLTM1201AD oral capsule before sleep
Study Details
Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. OSA patients show a marked reduction in upper airway (UA) dilator muscle activity at sleep onset and this phenomenon leads to increased collapsibility of UA compared to normal subjects. In this protocol the investigators will test the effect of LTM1201AZ, LTM1201AT, LTM1201AD, LTM1201AG administered before sleep on OSA phenotype traits and OSA severity during sleep.
Key Dates
- Start date
- Mar 1, 2019
- Status verified
- Sep 2022
- Primary completion
- Nov 30, 2022
- Completion
- Dec 31, 2022
Study Design
- Enrollment
- 16 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: PlaceboPlacebo capsule before bedtime
- Experimental: LTM1201AZLTM1201AZ capsule before bedtime
- Experimental: LTM1201ATLTM1201AT capsule before bedtime
- Experimental: LTM1201AGLTM1201AG capsule before bedtime
- Experimental: LTM1201ADLTM1201AD capsule before bedtime
Primary Outcome Measure
Apnea hypopnea Index (AHI, average number of events for every hour of sleep) [ Time Frame: 3 nights (treatment duration) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 |
Find similar trials in Boston, MA
By research site
Related Studies
- LinguaFlex Tongue Retractor (LTR) for the Treatment of OSA and Snoring in AdultsEnrolling By Invitation · Linguaflex, Inc. · Brighton, Massachusetts
- Prevalence and Impact of Obstructive Sleep Apnea in Multiple SclerosisRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Rescue Pharmacotherapy for OSAPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Atomoxetine and DAW2022 on OSA SeverityPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts